ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer
Carlsson, G.U., Guren, T.K., Haux, J., Pfeiffer, P., Taflin, H., Mavroudis, D., Georgoulias, V., Papadimitriou, C., Kentepozidis, N., Boumpas, D., Skintemo, L., Ganlöv, K.M.E., Gustavsson, B.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article